Influence
June 8, 2020

Conference sparks discussion about monitoring impact of healthcare AI

A Regenstrief Institute and Indiana Clinical and Translational Sciences Institute (CTSI) conference on the use of artificial intelligence (AI) in healthcare created a discussion about monitoring the impact of algorithms on care.

During the second day of the conference, Regenstrief President and Chief Executive Officer Peter Embí, M.D., M.S., made a case for “algorithmovigilance,” which is the systematic monitoring of healthcare algorithms to develop and respond to expected and unexpected effects. He stated he believes this surveillance is necessary to address and correct data biases as well as better understand the generalizability of algorithms.

The panel discussion was the subject of a Healthcare Innovation article.

Read the article

In addition to monitoring the impact of AI, the three-day conference, Artificial Intelligence: Applying Research and Engineering Solutions for Emergent Needs in Healthcare, covered the application of AI in healthcare settings, the necessary building blocks to create effective AI and the future applications of this technology.

More than 500 people from 16 countries signed up to attend.

Related News

Jiang Bian, PhD

Association between Trust of Researchers and Willingness to Participate in Alzheimer’s Disease Biomarker Research

Published in the JAMA Network Open. Here is a link to the article. Regenstrief Institute authors: Jiang Bian, PhD

Kathleen Unroe, M.D.

NEXT STEPs conference at Regenstrief Institute educates audience about including nursing home residents in clinical trials

The NEXT STEPs Conference, held at Regenstrief Institute on September 9-10, 2025, brought together a diverse group of clinical

Regenstrief Research Scientist Wanzhu Tu, PhD

Healthy eating and physical activity significantly lower sex-specific alcohol-attributable liver mortality in the United States

Published in the Journal of Hepatology. Here is a link to the article.  Regenstrief Institute author: Wanzhu Tu, PhD.

Johanne Eliacin and Sophia Wang

Association between Trust of Researchers and Willingness to Participate in Alzheimer’s Disease Biomarker Research

Published in the Alzheimer’s and Dementia. Here is a link to the article. Regenstrief Institute authors: Regenstrief Research Scientist